Academic appointed to Therapeutic Goods Administration as Specialist Advisor
Published: Monday 23rd January 2017
Dr Roger Lord from the School of Science (ACU, Brisbane) has been appointed to the Therapeutic Goods Administration (TGA) as a Specialist Advisor for organ and tissue transplantation and infectious diseases, bacteriology and virology, liver transplantation and clinical biochemistry.
Roger has been involved with the TGA for several years, having been a member of the Advisory Committee on Biologicals (ACB) in 2013, and two successive appointments (2015-16) to the Advisory Committee for the Safety of Medicines (ACSOM) and the Therapeutic Goods Committee (TGC) that dealt with standards for manufacture and supply of medicinal products.
A Federal Government review of TGA committee structure during 2016, resulted in a reduction from the 11 Advisory Committees to seven for 2017. ACSOM was amalgamated with two other committees into the Advisory Committee for Medicines (ACM) and the TGC abolished, duties spread over remaining committees in the restructure. Despite these reductions, and in order for the TGA to discharge its responsibilities effectively, expertise needed to be retained by appointment of individuals with certain skill sets as Specialist Advisors.
The need to use a specific skill set, to obtain advice, determines how often a Specialist Advisor will be invited to attend committee meetings. The restructure allows a Specific Advisor to be included in deliberations on any the new seven advisory committees as needed, and familiarity with TGA protocols and procedures, seen as an advantage as items actioned and completed in a more timely fashion.
Roger’s on-going role with the TGA is one that helps to safeguard and enhance the health of the Australian community while also ensuring that information on pharmaceutical, biological and device treatments is current and up to date, once made publically available, with regards to information provided in the ACU teaching curriculum.